Related references
Note: Only part of the references are listed.In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment
Guranda Chitadze et al.
ONCOIMMUNOLOGY (2017)
NKG2D-and T-cell receptor-dependent lysis of malignant glioma cell lines by human T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors
Guranda Chitadze et al.
ONCOIMMUNOLOGY (2016)
Stem cell markers in glioma progression and recurrence
Kirsten Hattermann et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Differential expression of CXCR4 and CXCR7 with various stem cell markers in paired human primary and recurrent glioblastomas
Charlote Fluh et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes
Esen Yonca Bassoy et al.
PLOS ONE (2016)
The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation
Larisa Pereboeva et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Effect of NKG2D ligand expression on host immune responses
Marine Champsaur et al.
IMMUNOLOGICAL REVIEWS (2015)
Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1
Vanessa Kruse et al.
PLOS ONE (2015)
Cancer stem cells: A contentious hypothesis now moving forward
Michael L. O'Connor et al.
CANCER LETTERS (2014)
Evolution of the Cancer Stem Cell Model
Antonija Kreso et al.
CELL STEM CELL (2014)
A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells
Fabian Wolpert et al.
NEURO-ONCOLOGY (2014)
Molecular and cellular heterogeneity: the hallmark of glioblastoma
Diane J. Aum et al.
NEUROSURGICAL FOCUS (2014)
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
Paula Codo et al.
ONCOTARGET (2014)
Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level
Justyna Kmiecik et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
Lawrence S. Lamb et al.
PLOS ONE (2013)
Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand
Kyohei Nakamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications
G. Chitadze et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2013)
The Cancer Stem Cell Subtype Determines Immune Infiltration of Glioblastoma
Christoph P. Beier et al.
STEM CELLS AND DEVELOPMENT (2012)
The Chemokine Receptor CXCR7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects
Kirsten Hattermann et al.
CANCER RESEARCH (2010)
Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients
Tiziano Di Tomaso et al.
CLINICAL CANCER RESEARCH (2010)
CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs)
Janka Held-Feindt et al.
EXPERIMENTAL CELL RESEARCH (2010)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Crypt stem cells as the cells-of-origin of intestinal cancer
Nick Barker et al.
NATURE (2009)
Stem cell marker CD133 affects clinical outcome in glioma patients
Felix Zeppernick et al.
CLINICAL CANCER RESEARCH (2008)
Soluble NKG2D ligands: prevalence, release, and functional impact
Helmut Rainer Salih
Frontiers in Bioscience-Landmark (2008)
Human NK Cells Kill Resting but Not Activated Microglia via NKG2D-and NKp46-Mediated Recognition
Anna Luenemann et al.
JOURNAL OF IMMUNOLOGY (2008)
NKG2D ligands in tumor immunity
N. Nausch et al.
ONCOGENE (2008)
Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity
Roberta Castriconi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells
Mattias Carlsten et al.
CANCER RESEARCH (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Human cytomegalovirus-encoded UL16 discriminates MIC molecules by their α2 domains
Jessica Spreu et al.
JOURNAL OF IMMUNOLOGY (2006)
Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients
NFS Watson et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
S Gasser et al.
NATURE (2005)
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
HR Salih et al.
BLOOD (2003)
Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein
J Wu et al.
JOURNAL OF IMMUNOLOGY (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro
TN Ignatova et al.
GLIA (2002)
Expression of stress-induced MHC class I related chain molecules on human melanoma
CS Vetter et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Share Paper
